The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
847
June 28, 1991
View Complete Issue         Table of Contents 2019 
Granulocyte Colony-Stimulating Factors
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Granulocyte Colony-Stimulating Factors
June 28, 1991 (Issue: 847)
The US Food and Drug Administration recently approved the marketing of G-CSF (recombinant human granulocyte colony-stimulating factor, generic name filgrastim, Neupogen - Amgen) and GM-CSF (recombinant human granulocyte-macrophage ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Granulocyte Colony-Stimulating Factors
Article code: 847a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.